Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients.
| Autor: | Hasvold, L P1, Bodegård, J2, Thuresson, M3, Stålhammar, J4, Hammar, N5, Sundström, J6, Russell, D7, Kjeldsen, S E8 |
|---|---|
| Zdroj: | Journal of Human Hypertension. Nov2014, Vol. 28 Issue 11, p663-669. 7p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|